LAUREN CINCOTTA: Open Payments
NPI 1083852792 · LINWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,296 in 139 payments from 19 companies in 2025. Trend: 2023 $1,170 · 2024 $1,721 · 2025 $2,296
Food & beverage: $2,118Education: $179
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $281 |
| Regeneron Healthcare Solutions, Inc. | 10 | $256 |
| Lilly USA, LLC | 10 | $239 |
| UCB, Inc. | 7 | $206 |
| Organon LLC | 23 | $191 |
| Almirall LLC | 18 | $187 |
| Arcutis Biotherapeutics, Inc. | 11 | $162 |
| Janssen Biotech, Inc. | 4 | $147 |
| LEO Pharma Inc. | 7 | $121 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $106 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, Seysara, Zoryve, TREMFYA, EBGLYSS, TALTZ.
Industry payments across NJ — which companies pay providers there.
